心通醫療-B(02160.HK)擬1.7億元收購上海佐心餘下49%股權
格隆匯5月30日丨心通醫療-B(02160.HK)公吿,於2025年5月30日,微創投資及上海佐擎(統稱為賣方)、公司的全資附屬公司上海微創心通(作為買方)與上海佐心訂立股權轉讓協議,據此,上海微創心通有條件同意收購以及微創投資及上海佐擎有條件同意出售上海佐心約35.27%及13.73%股權。收購事項的總代價為人民幣1.7億元。收購事項完成後,上海微創心通將持有上海佐心100%股權,而上海佐心將成為公司的全資附屬公司。
目標公司上海佐心為於2019年9月10日在中國成立的有限責任公司。截至本公吿日期,上海微創心通、微創投資及上海佐擎分別持有其約51.00%、35.27%及13.73%股權,因此,上海佐心為公司關連附屬公司。收購事項完成後,上海佐心將成為公司的全資附屬公司。
目標公司為高科技醫療器材公司,專注於左心耳相關醫療器材,主要擁有兩個自主研發的產品—AnchorMan®左心耳封堵系統及AnchorMan®左心耳導引系統。
公司認為,收購上海佐心餘下49%股權是一項戰略舉措,符合集團致力於醫療行業創新的承諾併為公司未來在治療結構性心臟病領域的成功奠定基礎,確保集團可充分獲取AnchorMan®左心耳封堵系統及AnchorMan®左心耳導引系統的商業化利益,從而使盈利能力及股東價值最大化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.